MilliporeSigma
2909 Laclede Ave. St. Louis, MO, USA
Join us and your peers for the Innovations in Upstream Development Technical Symposium for mAb and Gene Therapy. The days will cover the latest trends, developments and technologies to get upstream development right the first time.
Day 1 AM: Cell & Expression Technologies | |
---|---|
Platform process development of the next generation CHO expression system in Pfizer | Jin Guo, PhD Senior Scientist - Pfizer |
Meeting the challenges of supporting emerging modalities; Perspectives learned from the early days of exosome bioprocessing | Scott Estes, PhD Vice President, Process Sciences - Codiak BioSciences |
Alternative hosts: Moving beyond CHO for biologics manufacturing | Christina Alves, PhD, Principal Scientist - Biogen |
Panel discussion | Trissa Borgschulte, PhD, Senior Director and Head of Bioprocessing Upstream R&D - MilliporeSigma |
Lunch and Poster Session | |
Day 1 PM: Next Generation Processes | |
Facets of perfused seed train: Driving value towards the evolution of upstream processes | Habib Horry, PhD, Associate Director, Upstream Process Integration- MilliporeSigma |
Advances in upstream development at Just - Evotec Biologics | Myles Hollenbach, MS, Scientist, Small Scale Bioreactor Development - Just - Evotec Biologics |
Enabling advanced process control using process analytical technology in biopharmaceuticals manufacturing | Ravali Raju, PhD, Principal Scientist - Pfizer |
Panel discussion | Mike Phillips, PhD, Director, Next Generation BioProcessing R&D - MilliporeSigma |
Evening event - St. Louis Anheuser-Busch Brewery – Closing 8:30PM | |
Day 2 AM: Vaccine and Viral Therapy | |
Development and scale-up of an AAV manufacturing platform for gene transfer and gene editing vectors | Marissa Stanvick, Scientist II - Homology Medicines |
Towards the development of a templated process for LV and AAV manufacturing | Hank George, Head of Viral Vector Producing Cell Lines and Viral Gene Therapy Process Development - MilliporeSigma |
Impact of raw material variability on gene therapy modalities | Aaron Mack, PE, Senior Engineer - Biogen |
Panel discussion | Daniel Teasley, Senior Product Manager, Viral Gene Therapy Manufacturing - MilliporeSigma |
Lunch and Tour of our Center of Excellence | |
Day 2 PM: Next Generation Processes | |
Implementation of supplier upgrades in support of Next Generation Manufacturing | Philippe de Vilmorin, Senior Engineer - Biogen |
Biomanufacturing and development challenges in a rapid response world | Matt Caple, Executive Director Process Development - Ology Bioservices |
Case studies in biomanufacturing: Academic consortium perspective | Michael Betenbaugh, PhD, Professor, Chemical and Biomolecular Engineering - Johns Hopkins Univ., Lead PI, AMBIC |
Panel discussion | Omar Wahab, Head of Franchise - Upstream, Cell Culture and Biopharmaceutical Materials - MilliporeSigma |
Closing 3:45PM |